BioCryst Pharmaceuticals, Inc. (BCRX) — Dilution Risk Analysis
Current Snapshot
BioCryst Pharmaceuticals, Inc. (BCRX) has a DilutionWatch score of 22/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 22/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 5, FORM 4 5.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-09-02 | 0000882796-26-000057 |
| 4 | 2026-09-02 | 0000882796-26-000059 |
| 4 | 2026-09-02 | 0000882796-26-000061 |
| 4 | 2026-09-02 | 0000882796-26-000063 |
| 4 | 2026-09-02 | 0000882796-26-000065 |
| Form 4 | 2026-08-31 | 0000882796-26-000065|0001385496|2026-08-31|A|644 |
| Form 4 | 2026-08-31 | 0000882796-26-000063|0001644246|2026-08-31|A|1288 |
| Form 4 | 2026-08-31 | 0000882796-26-000061|0001187159|2026-08-31|A|1159 |
| Form 4 | 2026-08-31 | 0000882796-26-000059|0001883764|2026-08-31|A|644 |
| Form 4 | 2026-08-31 | 0000882796-26-000057|0001583886|2026-08-31|A|1288 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 22 months | Source |
| Three-year share count growth | 24.77% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 22/10) Source
- Cash Runway
- 22 months Source
- Share Count Growth (3-Year)
- 24.77% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.